ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press

April 10, 1987

Annual Report to the Nation Shows Decline In Overall Cancer Death Rates

January 11, 2013

List of FY97 SPORE Grantees and Their Awards

December 12, 1997

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997

Health Care Reform: Fundamental changes Ahead For Cancer Research And Care

October 8, 1993